HK1016897A1 - Use of transduced myogenic cells for relieving pain and for treating behavioral and perceptive abnormalities - Google Patents

Use of transduced myogenic cells for relieving pain and for treating behavioral and perceptive abnormalities

Info

Publication number
HK1016897A1
HK1016897A1 HK99102199A HK99102199A HK1016897A1 HK 1016897 A1 HK1016897 A1 HK 1016897A1 HK 99102199 A HK99102199 A HK 99102199A HK 99102199 A HK99102199 A HK 99102199A HK 1016897 A1 HK1016897 A1 HK 1016897A1
Authority
HK
Hong Kong
Prior art keywords
myogenic cells
perceptive
abnormalities
peptide
relieving pain
Prior art date
Application number
HK99102199A
Other languages
English (en)
Inventor
Peter K Law
Original Assignee
Cell Therapy Res Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Therapy Res Foundation filed Critical Cell Therapy Res Foundation
Publication of HK1016897A1 publication Critical patent/HK1016897A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK99102199A 1997-08-11 1999-05-18 Use of transduced myogenic cells for relieving pain and for treating behavioral and perceptive abnormalities HK1016897A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5519997P 1997-08-11 1997-08-11

Publications (1)

Publication Number Publication Date
HK1016897A1 true HK1016897A1 (en) 1999-11-12

Family

ID=21996302

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99102199A HK1016897A1 (en) 1997-08-11 1999-05-18 Use of transduced myogenic cells for relieving pain and for treating behavioral and perceptive abnormalities

Country Status (7)

Country Link
US (1) US7166279B2 (xx)
EP (1) EP0898967B1 (xx)
JP (1) JPH11147829A (xx)
AT (1) ATE241992T1 (xx)
CA (1) CA2225185A1 (xx)
DE (1) DE69815230T2 (xx)
HK (1) HK1016897A1 (xx)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2378643A1 (en) 1999-07-23 2001-02-01 Diacrin, Inc. Muscle cells and their use in cardiac repair
PL366000A1 (en) * 2000-08-08 2005-01-24 M.G.V.S.Ltd. Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis
WO2003039344A2 (en) * 2001-11-08 2003-05-15 The Regents Of The University Of California Methods and compositions for correction of cardiac conduction disturbances
JP4549609B2 (ja) * 2002-04-11 2010-09-22 エスエス製薬株式会社 被覆固形催眠製剤
AU2003239418B2 (en) * 2002-05-08 2008-01-31 The Regents Of The University Of California System and method for forming a non-ablative cardiac conduction block
US6932804B2 (en) * 2003-01-21 2005-08-23 The Regents Of The University Of California System and method for forming a non-ablative cardiac conduction block
US20040106896A1 (en) * 2002-11-29 2004-06-03 The Regents Of The University Of California System and method for forming a non-ablative cardiac conduction block
US7317950B2 (en) * 2002-11-16 2008-01-08 The Regents Of The University Of California Cardiac stimulation system with delivery of conductive agent
EP1740198A4 (en) * 2004-04-26 2009-03-04 Immuneregen Biosciences Inc ANTI-AGING EFFECT OF SUBSTANCE P
US8889122B2 (en) 2005-05-09 2014-11-18 Mytogen, Inc. Cellular cardiomyoplasty as supportive therapy in patients with heart disease
US20090017080A1 (en) * 2007-03-15 2009-01-15 Paul Robert Tanner Personal care kit having skin care compositions with a readily perceptible difference
WO2008157348A1 (en) * 2007-06-13 2008-12-24 The Procter & Gamble Company Skin treatment device
CN102026598B (zh) * 2008-05-15 2015-01-14 惠氏有限责任公司 提供皮肤益处的方法
US20100224205A1 (en) * 2008-12-09 2010-09-09 Shekhar Mitra Device and methods for modifying keratinous surfaces
JP2012515063A (ja) 2009-01-16 2012-07-05 ザ プロクター アンド ギャンブル カンパニー 角質表面を改質するための装置及び方法
US20150050300A1 (en) 2013-08-16 2015-02-19 Peter K. Law Disease prevention and alleviation by human myoblast transplantation
KR101920548B1 (ko) 2014-06-13 2018-11-20 더 프록터 앤드 갬블 캄파니 각질 표면을 변경하는 장치 및 방법
US10156036B2 (en) 2014-06-13 2018-12-18 The Procter & Gamble Company Device and methods for applying compositions to fabric surfaces
CN106457288B (zh) 2014-06-13 2021-05-11 宝洁公司 改变角质表面的设备和方法
US20160114349A1 (en) 2014-06-13 2016-04-28 The Procter & Gamble Company Device and methods for depositing materials on hard surfaces
EP3154642A2 (en) 2014-06-13 2017-04-19 The Procter & Gamble Company Treatment compositions, apparatus and methods for modifying keratinous surfaces
EP3154417A2 (en) 2014-06-13 2017-04-19 The Procter & Gamble Company Apparatus and methods for modifying keratinous surfaces
US10518291B2 (en) 2014-06-13 2019-12-31 The Procter & Gamble Company Device and methods for modifying surfaces
US9924875B2 (en) 2014-06-13 2018-03-27 The Procter & Gamble Company Apparatus and methods for modifying keratinous surfaces
KR102040452B1 (ko) 2014-06-13 2019-11-04 더 프록터 앤드 갬블 캄파니 각질 표면 상의 처리 조성물의 침착을 위한 카트리지
US9949552B2 (en) 2014-07-25 2018-04-24 The Procter & Gamble Company Handheld treatment apparatus for modifying keratinous surfaces
US10314378B2 (en) 2014-07-25 2019-06-11 The Procter & Gamble Company Cartridge assembly for a dispensing device
US9955769B2 (en) 2014-07-25 2018-05-01 The Procter & Gamble Company Applicator heads for handheld treatment apparatus for modifying keratinous surfaces
US10188193B2 (en) 2014-07-25 2019-01-29 The Procter & Gamble Company Applicator heads for handheld treatment apparatus for modifying keratinous surfaces
US11083880B2 (en) 2014-07-25 2021-08-10 The Procter & Gamble Company Angled cartridge assembly for a dispensing device
WO2016200440A1 (en) 2015-06-11 2016-12-15 The Procter & Gamble Company Device and methods for applying compositions to surfaces
US9949547B2 (en) 2015-06-11 2018-04-24 The Procter & Gamble Company Cartridges for use in an apparatus for modifying keratinous surfaces
US9962532B2 (en) 2015-06-11 2018-05-08 The Procter & Gamble Company Cartridges for use in an apparatus for modifying keratinous surfaces
US11116302B2 (en) 2015-06-11 2021-09-14 The Procter & Gamble Company Apparatus and methods for modifying keratinous surfaces
US9616668B1 (en) 2015-12-07 2017-04-11 The Procter & Gamble Company Servicing cassettes for handheld fluid jet apparatuses for use in modifying surfaces
US10166799B2 (en) 2015-12-07 2019-01-01 The Procter & Gamble Company Service stations for handheld fluid jet apparatuses
US10391042B2 (en) 2015-12-07 2019-08-27 The Procter & Gamble Company Treatment compositions, apparatus and methods for modifying keratinous surfaces
US11090238B2 (en) 2017-06-16 2021-08-17 The Procter & Gamble Company Array of cosmetic compositions for camouflaging tonal imperfections
JP2020523337A (ja) 2017-06-16 2020-08-06 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ 皮膚の色のムラをカモフラージュするためのコンピュータ支援測色メークアップ方法
KR102345921B1 (ko) 2017-06-16 2022-01-04 더 프록터 앤드 갬블 캄파니 가청 피드백을 갖는 개인 케어 장치
WO2021089162A1 (en) 2019-11-07 2021-05-14 L'oreal Microdermabrasion device for coloring the skin
WO2023102287A1 (en) 2021-12-03 2023-06-08 The Procter & Gamble Company Personal care device with audible feedback

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE77033B1 (en) * 1989-08-16 1997-11-19 Univ Tulane Substance P antagonists
WO1992016547A1 (en) * 1991-03-15 1992-10-01 The Children's Medical Center Corporation Controlling nk-1 receptor-mediated responses and related diagnostics
CN1127343C (zh) * 1994-12-13 2003-11-12 彼得·K·罗 治疗哺乳动物疾病的成肌细胞组合物

Also Published As

Publication number Publication date
DE69815230D1 (de) 2003-07-10
US20020044925A1 (en) 2002-04-18
EP0898967A1 (en) 1999-03-03
ATE241992T1 (de) 2003-06-15
EP0898967B1 (en) 2003-06-04
CA2225185A1 (en) 1999-02-11
JPH11147829A (ja) 1999-06-02
DE69815230T2 (de) 2004-05-06
US7166279B2 (en) 2007-01-23

Similar Documents

Publication Publication Date Title
HK1016897A1 (en) Use of transduced myogenic cells for relieving pain and for treating behavioral and perceptive abnormalities
NZ505011A (en) Expression vectors and cell lines expressing VEGF-D and method of treating melanomas
US6895271B2 (en) Iontophoretic drug delivery electrodes and method
TW286286B (xx)
GB9211085D0 (en) Electrical stimulation
US20040138712A1 (en) Combination stimulating and exothermic heating device and method of use thereof
ATE127028T1 (de) Einpflanzbares iontophoretisches abgabesystem.
HK1030853A1 (en) Transdermal therapeutic device with capsaicin and capsaicin analogs
EP0653918A4 (en) CONDUCTIVE HEART STIMULATOR AND INTEGRATED OXYGEN PROBE.
GB9817662D0 (en) Substance delivery
ES2161246T3 (es) Factor transformante de crecimiento alfa h1.
Wheatley et al. A comparison of intact and in-vitro locomotion in an adult amphibian
HUT53816A (en) Method for elaborating therapeutical system feeding the agent gradually through the skin
AU5732190A (en) Glycoprotein hormone receptor molecules
CA2343893C (en) Iontophoretic drug delivery electrodes
DE69825322D1 (de) Topische carbamazepin-formulierungen und deren verwendung
CN2164852Y (zh) 全息胚穴位电极带
DE69230063D1 (de) Elektrisches Gerät zur transdermalen Verabreichung von Medikamenten mit einem entgegenwirkenden Produkt
Wakelee-Lynch Interferon may offer first drug therapy for diabetic retinopathy. New research showing that alpha-interferon blocks new blood vessel formation in the iris of monkeys may point the way to new treatment for diabetes retinopathy
Disselhoff Transcutaneous electrical nerve stimulation (TENS) in neuropathic pain
Qiang et al. Effect of auriculoacupuncture on life quality of patients with malignant tumors
Tech Cardiovascular disease
Nix Changes in activity level as an aftereffect of stress
王殿洪 et al. PURIFICATION AND CHARACTERIZATION OF INSULIN RECEPTORS FROM HUMAN PLACENTA
UA26886C2 (uk) Солі 1,3-діарил-4,5-поліметилеhімідазолію, що виявляють аhальгезуючу активhість

Legal Events

Date Code Title Description
AS Change of ownership

Owner name: PETER KOI LAW

Free format text: FORMER OWNER(S): CELL THERAPY RESEARCH FOUNDATION

PF Patent in force
CHPA Change of a particular in the register (except of change of ownership)
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110407